Merian Life Sciences ApS: Financial statements 2020
CVR: 40288589
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Merian Life Sciences ApS (CVR 40288589) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 457,443 and a net result of DKK 334,417 compared with DKK 233,925 the year before. That is an increase of 32.5% compared with the year before. Equity in the 2020 report amounted to DKK 619,353. The solvency ratio was 62.4%.
- Gross Profit
- DKK 457,443
- Profit/Loss
- DKK 334,417
- Equity
- DKK 619,353
- Total Assets
- DKK 992,633
- Employees
- 0
Official annual report
How creditworthy is Merian Life Sciences ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Merian Life Sciences ApS has published its interim report for the period February 25, 2019 to December 31, 2019.
About Merian Life Sciences ApS
Merian Life Sciences ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Birgitte Menachem and Neil Goldsmith. The company is owned by Birgitte Menachem and Neil Goldsmith. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 280,804 and a net result of DKK -36,911 compared with DKK 835,491 the year before. Equity in the 2025 report amounted to DKK 2,002,914.